ADL
PHXM

Asset Dedication LLC’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Asset Dedication LLC’s Portfolio PHXM Stock Details PHXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-400
Closed -$1K – 1235
2024
Q1 		$1K Hold
400
– – ﹤0.01% 969
2023
Q4 		$2K Hold
400
– – ﹤0.01% 918
2023
Q3 		$2K Hold
400
– – ﹤0.01% 917
2023
Q2 		$3K Hold
400
– – ﹤0.01% 852
2023
Q1 		$4K Hold
400
– – ﹤0.01% 793
2022
Q4 		$1K Hold
400
– – ﹤0.01% 977
2022
Q3 		$2K Buy
+400
New +$3.96K ﹤0.01% 855

Asset Dedication LLC's PHXM Position: Q2 2024 in Review

Asset Dedication LLC sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q2 2024, closing a stake of 400 shares — an estimated $1K sold.

Asset Dedication LLC first reported a position in PHXM in Q3 2022 and held it in 7 quarters. The position peaked at $4K in Q1 2023. 0 funds tracked by Wall St. Rank hold PHXM as of Q2 2024.

  • Asset Dedication LLC reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q2 2024 after selling out during the quarter.
  • Asset Dedication LLC sold 400 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q2 2024, an estimated $1K.
  • Asset Dedication LLC first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q3 2022 and held it in 7 quarters.
  • Asset Dedication LLC's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $4K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q2 2024.

Based on Asset Dedication LLC's 13F filing for Q2 2024, filed 6 Aug 2024.